Onivyde

Onivyde Description

irinotecan

Manufacturer:

Ipsen Pharma

Distributor:

DKSH

Marketer:

Servier
Full Prescribing Info
Description
White to slightly yellow opaque isotonic liposomal dispersion.
One 10 ml vial of concentrate contains 43 mg irinotecan anhydrous free base (as irinotecan sucrosofate salt in a pegylated liposomal formulation).
One ml of concentrate contains 4.3 mg irinotecan anhydrous free base (as irinotecan sucrosofate salt in a pegylated liposomal formulation).
The concentrate has a pH of 7.2 and an osmolality of 295 mOsm/kg.
Excipient with known effect: One ml of concentrate contains 0.144 mmol (3.31 mg) sodium.
Excipients/Inactive Ingredients: Liposome forming lipids: 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), Cholesterol, N-(carbonyl-methoxypolyethylene glycol-2000)-1, 2-distearoly-sn-glycero-3-phosphoethanolamine (MPEG-2000-DSPE).
Other excipients: Sucrose octasulphate, 2-[4-(2-Hydroxyethyl)piperazin-1-yl] ethanesulfonic acid (HEPES buffer), Sodium chloride, Water for injections.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in